semaglutide molecule Antidiabetic drug molecular structure, illustration - Stock Image - C059/2721 Semaglutide CAS 99291-20-0 Manufacturers, Suppliers,

Description

It is not the first-choice injectable for uncomplicated Type 2 diabetes anymore, and understanding this shift helps explain why the GLP-1 question comes up so often

Now that we understand the health risks of obesity, we know that this chronic disease requires lifelong treatment. Consider This When Preparing to Stop Weight-Loss Drugs Some people opt to stop taking weight-loss medications because of their side effects, which can include nausea, diarrhea and constipation

Is the tablet the same as the injection

This means Ozempics weight-loss potential likely falls somewhere between these two trial results, though it remains lower than Mounjaro in equivalent-dose comparisons

Statin therapy is recommended for most adults with diabetes aged 40-75 years, with at least moderate-intensity statins for most patients and high-intensity statins indicated for those with established ASCVD or multiple risk factors